Chemical cardiac sympathetic denervation hampers defibrillation in the dog

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 1, 1997, Pages 62-67

  Ruffy, Rodolphe ^a,b   Leonard, Michael ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b CardioScript International   (United States)

Author keywords

6 hydroxydopamine; autonomic nervous system; defibrillation; sympathetic denervation

Indexed keywords

ASCORBIC ACID; OXIDOPAMINE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DEFIBRILLATION; DOG; ELECTROPHYSIOLOGY; ENERGY; HEART DENERVATION; IMPEDANCE; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC INNERVATION;

EID: 0031055873     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb00609.x     Document Type: Article

References (11)

1. Ruffy R, Schechtman K, Monje E: Beta-adrenergic modulation of direct defibrillation energy in the anesthetized dog heart. Am J Physiol 1985;248(Heart Circ Physiol 17):H674-H677.
2. Ruffy R, Schechtman K, Monje E, et al: Adrenergically mediated variations in the energy required to defibrillate the heart. Observations in closed-chest, non-anesthetized dogs. Circulation 1986;73:374-380.
3. Rattes MF, Sharma AD, Klein GJ, et al: Adrenergic effects on internal cardiac defibrillation threshold. Am J Physiol 1987;253(Heart Circ Physiol 22): H500-H506.
4. Ruffy R, Monje E, Schechtman K: Facilitation of cardiac defibrillation by aminophylline in the conscious closed-chest dog. J Electrophysiol 1988;2:450-454.
5. Alter WA, Weiss GK, Priola DV, et al: The effects of 6-hydroxydopamine on vagal cardioaccelerator systems. J Pharmacol Exp Ther 1973;187:99-104.
6. Naccarelli GV, Dougherty AH, Wolbrette D: Antiarrhythmic drug-implantable cardioverter-defibrillator interactions. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders, Philadelphia, 1995, p. 1426.
7. Burt JM, Spray DC: Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol 1988;254:H1206-H1210.
8. De Mello WC: Effect of isoproterenol and 3-isobutyl-1-methylxanthine on junctional conductance in heart cell pairs. Biochim Biophys Acta 1989;1012: 291-298.
9. Jung W, Manz M, Pizzulli L, et al: Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol 1992;70:1023-1027.
10. Davy JM, Fain ES, Dorian P, et al: The relationship between successful defibrillation and delivered energy in open-chest dogs: Reappraisal of the "defibrillation threshold" concept. Am Heart J 1987;113:77.
11. Jones DL, Irish WD, Klein GJ: Defibrillation efficacy: Comparison of defibrillation threshold versus dose-response curve determination. Circ Res 1991;69:45-51.